Trivitron’s Labsystems Diagnostics in agreement with Baebies

first_imgTrivitron’s Labsystems Diagnostics in agreement with Baebies Share MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app News By EH News Bureau on September 11, 2017 Related Posts Baebies will distribute Labsystems’ newborn screening products in the US after obtaining regulatory clearanceTrivitron’s Labsystems Diagnostics announced their collaboration with US-based Baebies, a company focussed on advancing newborn screening (NBS) and paediatric testing. Both the companies have declared a joint bilateral distribution agreement to deliver a wider range of NBS solutions across several global markets.Baebies, will distribute Labsystems’ newborn screening products in the US after obtaining regulatory clearance, while Labsystems will distribute Baebies’ SEEKER platform internationally. center_img WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” The missing informal workers in India’s vaccine story Menopause to become the next game-changer in global femtech solutions industry by 2025 Read Article Phoenix Business Consulting invests in telehealth platform Healphalast_img read more

Cipla and Wellthy Therapeutics announce digital therapeutics for diabetes and CVDs

first_img Share Phoenix Business Consulting invests in telehealth platform Healpha Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app Cipla and Wellthy Therapeutics (Wellthy Therapeutics) have announced that they have entered into a partnership to offer a combination of pharmacotherapy and digital therapeutics for improved patient outcomes in the chronic therapies of diabetology and cardiology.Under the agreement, a multi-lingual clinically-validated digital disease management platform will be made available to patients living with diabetes or cardiovascular diseases via doctors’ clinics or co-packaging on select Cipla brands. The platform brings together behavioural science, real-world clinical evidence and artificial intelligence to provide real-time monitoring, coaching and advice to patients, and virtual clinical assistance to doctors.This partnership is a result of Cipla’s campaign, Innoventia, which was envisioned as a first-of-its-kind challenge by an Indian pharmaceutical company to encourage innovation-led entrepreneurship and to harness disruptive ideas in healthcare to fulfil unmet patient needs.Umang Vohra, MD and Global CEO, Cipla, said, “The future of healthcare will be driven by increased use of technology, and this partnership gives Cipla the ability to offer this combination of prescription drugs and artificial intelligence-powered digital therapeutics to patients in cardio-metabolic health. It will allow patients to make informed decisions and take charge of their own health. By pairing our pharmacotherapy strengths with the digital approach to healthcare taken by Wellthy Therapeutics, Cipla will add to its diversified portfolio in the cardio-metabolic area to provide holistic care to patients from awareness, diagnosis and compliance to well-being.”Abhishek Shah, Co-founder and CEO, Wellthy Therapeutics, said, “We are excited to work with Cipla to bring digital therapeutics to patients in India. Companion digital therapeutics are redefining the treatment of chronic conditions, by helping personalise and simplify disease management for patients, and driving precision clinical insights to clinicians. With the combination of Cipla’s world- class formulations and clinically-validated digital therapeutics of Wellthy Therapeutics, we look forward to helping empower and inspire millions of patients to achieve better, sustainable health outcomes.”Cardiovascular Diseases (CVDs) are the leading cause of mortality in India today, cutting across the urban-rural divide. Diabetes and hypertension are significant risk factors leading to CVDs. Over 72 million Indians are estimated to be diabetic, while approximately 10 per cent of the population is estimated to be pre-diabetic, and 29 per cent of the population is estimated to be hypertensive. MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Menopause to become the next game-changer in global femtech solutions industry by 2025 The missing informal workers in India’s vaccine story WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals Cipla and Wellthy Therapeutics announce digital therapeutics for diabetes and CVDs This partnership is a result of Cipla’s campaign, Innoventia, which was envisioned as a first-of-its-kind challenge by an Indian pharmaceutical company to harness disruptive ideas in healthcare Read Article Related Posts By EH News Bureau on February 19, 2019 News Comments (0) Abhishek Shahcardiovascular diseasesCiplaCVDsDiabetesdigital therapeuticsInnoventiaUmang VohraWellthy Therapeutics Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Add Commentlast_img read more

Gavi, NEC and Simprints sign MoU

first_imgGavi, NEC and Simprints sign MoU Share Menopause to become the next game-changer in global femtech solutions industry by 2025 To deploy world’s first scalable child fingerprint identification solution to boost immunisation in developing countriesGavi, the Vaccine Alliance, NEC Corporation, and Simprints Technology have signed a memorandum of understanding on the use of biometrics to improve immunisation coverage in developing countries.Despite enormous progress over the past two decades, there are still approximately 20 million children (*1) who do not receive a basic course of vaccines worldwide, leaving them exposed to some of the world’s deadliest diseases.One key cause is the fact that only half of all children under 5 in sub-Saharan Africa are currently registered at birth, leaving many without an official identity. This makes it difficult for health practitioners to ensure these infants get the vaccines they need at the right time.Guided by Gavi’s experience and expertise in immunisation, this new project will combine Simprints’ biometric fingerprint technology and NEC’s reinforced authentication engine to help create digital identities for children one to five years of age and boost immunisation coverage in developing countries.This new partnership will deploy the world’s first scalable fingerprint identification solution to give children aged 1-5 a digital ID linked to an accurate, complete medical record. All biometric records will be stored securely by Simprints, a UK-based non-profit social enterprise, after caregivers give informed consent to taking their children’s biometric data.Implementing this plan with conventional extraction and matching engines would be very challenging, since young children’s fingerprints tend to be blurred due to their softness. NEC’s fingerprint authentication engine has overcome this issue, with optimisation for infant fingerprints and the use of fingerprint images taken with Simprints scanners. This combination has resulted in highly accurate authentication, with a certification rate of 99 per cent.The three partners will begin carrying out proof of concept validation of the technology in Bangladesh and Tanzania by early 2020. If successful, the project will then progress to linking children’s digital identity with their vaccination record, helping health practitioners to track which children need to be vaccinated and when.This initiative helps to promote the 17 Sustainable Development Goals (SDGs) established by the United Nations, particularly Goal 3 of ensuring healthy lives for all people of all ages and promoting welfare. This includes provision 3.8 for achieving universal health coverage (UHC), including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all. Comments (0) GaviimmunisationNEC CorporationSimprints TechnologyVaccine Alliance Related Posts Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app The missing informal workers in India’s vaccine story WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals By EH News Bureau on June 6, 2019 News Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Phoenix Business Consulting invests in telehealth platform Healpha MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Read Article Add Commentlast_img read more

IIT Delhi’s COVID-19 testing kit to be manufactured by Bengaluru-based biotech firm

first_img Genei Laboratories will produce the kits at the Andhra Pradesh MedTech Zone in VisakhapatnamIIT Delhi”s low-cost COVID-19 testing kit will be produced by a Bengaluru-based biotechnology firm and is expected to be available by the first week of June, according to officials.The large scale assembly and manufacturing of the kits by Genei Laboratories will be carried out at a facility exclusively set up for COVID-19 testing kits at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam.“Genei Laboratories is one of the companies which has received the non exclusive license from IIT Delhi for the Probe free RT-PCR based COVID-19 low cost test kit,” Indian Institute of Technology Delhi Director V Ramgopal Rao said.IIT Delhi, which has become the first academic institute to develop a COVID-19 testing method, is planning to give non-exclusive open licence to companies for commercialising the test, but with a price rider. While the institute has kept a price rider of Rs 500 per kit, Genei Laboratories has not announced the price yet.“We are delighted to enter into a partnership with IIT Delhi for further development and commercialisation of this unique detection assay for COVID-19,” Genei Laboratories Managing Director S Chandrashekaran said.“Using their unique technology and our expertise in reagent and kit-making, we will ensure an accurate, affordable, Make-in-India kit for the diagnosis of Sars-CoV2,” Chandrashekaran said.“Further, Genei Laboratories expects to manufacture the most affordable real time PCR testing Kits for COVID19 in India,” he said. “The final kit will have two variants and is expected to be rolled out of AMTZ campus by June first week of 2020.”The company is among the 40 companies to have reached out to the institute after it got an approval from the Indian Council of Medical Research for the test based on a real-time PCR-based diagnostic assay.According to the team, the current testing methods available are ‘probe-based’, while the one developed by IIT Delhi is a ‘probe-free’ method, which reduces the testing cost without compromising on accuracy.Using comparative sequence analyses, the IIT Delhi team identified unique regions (short stretches of RNA sequences) in the COVID-19 and SARS COV-2 genome. Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Read Article Andhra Pradesh Medtech ZoneCOVID-19Genei LaboratoriesIIT Delhi WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals Phoenix Business Consulting invests in telehealth platform Healpha News By Press Trust of India on May 13, 2020 Related Posts Comments (0) MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Menopause to become the next game-changer in global femtech solutions industry by 2025 IIT Delhi’s COVID-19 testing kit to be manufactured by Bengaluru-based biotech firm Share Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app The missing informal workers in India’s vaccine story Add Commentlast_img read more

Indian-American doctor writes to West Bengal govt says COVID-19 exceptionally infective highly lethal

first_img News WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app The missing informal workers in India’s vaccine story Indian-American doctor writes to West Bengal govt says COVID-19 exceptionally infective highly lethal Share Related Posts West Bengal is exceptionally crowded, the virus, if it infects a particular locality, will spread like wildfire, affecting thousands and killing quite a fewDescribing the coronavirus as exceptionally infective and highly lethal, an eminent Indian-American cardiologist has urged West Bengal Chief Minister Mamata Banerjee not to take anything for granted and take all necessary steps to prevent large-scale illness and fatalities in the state.According to a report filed by Lalit K Jha from PTI,  Tennessee-based Dr Indranill Basu Ray, in a letter to Banerjee, said that India, including West Bengal, may be lucky because of a different viral strain not having such a severe infection.“I am compelled to point out the fact that as West Bengal is exceptionally crowded, the virus, if it infects a particular locality, will spread like wildfire, affecting thousands and killing quite a few,” he said.It is essential to maintain strict social distancing and ensure that this dangerous virus could be prevented from spreading and killing as it has been doing in certain western countries, the cardiologist said in his letter.“We cannot take anything for granted as you will regret if thousands are infected, and hundreds start dying because of a lack of strictness in preventing the spread and appropriate detection of COVID-19.“I would therefore kindly request you to take urgent steps to realise the deadliness of this virus and the fact that it is a killing machine. Appropriate measures, including augmented testing, isolation of all contacts, and forceful enforcement of the lockdown, are mandatory to prevent the exact scenario as seen in the west,” he said, adding that the coronavirus is exceptionally infective and highly lethal.Dr Ray, a cardiologist and cardiac electrophysiologist who has also been a Professor of medicine and public health at multiple universities in the US and India, expressed shock that instead of doctors, a committee has been asked to provide COVID-19 death certificates.“Hushing up such infection and not taking appropriate precautions like isolation would lead to death and destruction, which I certainly know that you would not like as the Chief Minister of my state,” he added. Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Menopause to become the next game-changer in global femtech solutions industry by 2025 COVID-19Dr Indranill Basu RayMamata Banerjee Phoenix Business Consulting invests in telehealth platform Healpha By Press Trust of India on May 12, 2020 Add Comment Read Article Comments (0)last_img read more

Wockhardt Hospital Mira Road celebrates International Nurses Day

first_img The missing informal workers in India’s vaccine story By EH News Bureau on May 18, 2020 Related Posts Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app Read Article News Share Wockhardt Hospital Mira Road celebrates International Nurses Day WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Plans various online competitions, more than 100 nurses participateOn the occasion of International Nurses Day, Wockhardt Hospital, Mira Road planned various competitions for the through online mode. This year, the theme was Nurses: A Voice to Lead – Nursing the World to Health. More than 100 nurses participated in the activity.Various online competitions were organised for the nurses that include drawing, solo dance and singing, and individual quiz competition. The winners were for (Song  1st prize went to Sona Biju, 2nd prize to Athira, 3rd prize to Bency and Lijimol Biju. The dance winners were: 1st prize to Anju Lalu, 2nd prize to Jyoti and Sonal,  3rd prize to Neethu. In the drawing competition, the 1st prize went to Shabana, 2nd prize to Priti Sawand and Princy and 3rd prize to Feby. In the quiz competition, the 1st prize went to Sabita, the 2nd Prize to Sherin and the 3rd prize to Ritu.Chief of Nursing, Lissymol Saji, Wockhardt Hospital, Mira Road addressed “All the nurses from the hospital are working relentlessly for the benefit of the patients leaving all their problems behind. We thank the hospital for taking care of us and ensuring our safety. We are glad that the hospital organised activities for us to help us rejuvenate and become stress-free. We all are happy and thankful to the hospital on behalf of all the nurses. We look forward to working for the betterment of the society, and hope to keep serving the patients till our last breath. We have also pledged to stand strong and fight against coronavirus.”Dr Pankaj Dhamija, Center head, Wockhardt Hospital, Mira Road, said, “I am glad that the whole team of nurses has shown their real zeal of responsibility and ownership and for their complete commitment and dedication in spite of the challenges faced during the lockdown.” International Nurses DayNurseWockhardt Hospital Mira Road Phoenix Business Consulting invests in telehealth platform Healpha Add Comment Menopause to become the next game-changer in global femtech solutions industry by 2025 Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Comments (0)last_img read more

V Simpson Emmanuel appointed as General Manager, Roche Products (India)

first_img News By EH News Bureau on June 3, 2020 Read Article Menopause to become the next game-changer in global femtech solutions industry by 2025 Phoenix Business Consulting invests in telehealth platform Healpha Add Comment Central Eastern EuropeGeneral ManagerRoche IndiaRoche Products IndiaRussia & Indian SubcontinentTurkeyV Simpson Emmanuel Simpson has extensive experience of over 20 years in the pharmaceutical industry, across functions such as marketing, strategic planning, sales management, new product planning and accessRoche today announced the appointment of V Simpson Emmanuel as General Manager for Roche Products (India)  after a leadership change in December 2019.Simpson has an extensive experience of over 20 years in the pharmaceutical industry, across functions such as marketing, strategic planning, sales management, new product planning and access. He has led various functions and teams at a national as well as global level since he joined Roche in September 2014.“I am pleased to announce Simpson as the new General Manager for Roche India.” said Adriano Treve, Area Head – Central Eastern Europe, Turkey, Russia & Indian Subcontinent (CEETRIS), Roche. “Simpson has a deep understanding of the healthcare sector and with his strong diverse experience, I am confident he will guide the company to deliver better outcomes for more patients in India. India is a priority for Roche and I believe he will find new ways to shape the healthcare ecosystem together with our customers and embrace next generation ideas and technologies that can transform the lives of patients.”“I feel honoured to be stepping into this new role in these unique times. As we keep on working towards providing medical care to patients, I know that the current challenges in healthcare will only strengthen our intent to serve patients and drive excellence.” said Simpson. “We will continue to work passionately to make an impact on patient’s lives, focussing on delivering innovative solutions and collaborating with each stakeholder in the Indian healthcare ecosystem.”Simpson holds a Master’s degree in Health Economics from the University of York, UK, a Post-graduate Diploma in Business Administration in Marketing & Systems and a Bachelor’s degree in Physics. V Simpson Emmanuel appointed as General Manager, Roche Products (India) WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Comments (0) The missing informal workers in India’s vaccine story Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Share Related Posts Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care applast_img read more

Netmagic partners with VMware to launch SimpliInsight Services

first_img Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Related Posts WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals AWSAzureCloud servicesGoogle Cloud PlatformNetmagicSimpliInsight ServicesVMwareVMware CloudHealth The missing informal workers in India’s vaccine story News Netmagic partners with VMware to launch SimpliInsight Services MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Read Article By EH News Bureau on June 30, 2020 Share Phoenix Business Consulting invests in telehealth platform Healpha Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app The services will deliver consistent, actionable view into cost, resource management, security, performance for applications across multiple cloud environmentsNetmagic today announced its partnership with VMware to launch SimpliInsight Services powered by VMware CloudHealth service in India.With SimpliInsight Services powered by VMware CloudHealth, Netmagic. SimpliInsight Services powered by VMware CloudHealth will help Netmagic’s customer realise costs saving across multi-cloud deployments such as Azure, AWS, Google Cloud Platform (GCP), etc.“We are extremely pleased to partner with VMware. Netmagic’s SimpliInsight service powered by VMware CloudHealth will support businesses with in-depth visibility on cost, performance and security – allowing our customers to make informed strategic decisions for their deployments across hyperscalers like AWS, Azure and Google,” said Nitin Mishra, Senior Executive Vice President and Chief Product Officer, Netmagic.Pradeep Nair, Managing Director, VMware India, “Cloud infrastructure services spend hit yet another record in Q1 2020, growing 34 per cent (YoY) to $31 billion[1]. This growth in cloud services is driven in no small part by the global shift to remote working and increased push for digital transformation. Organisations in India are cognisant of the value delivered by cloud and we are witnessing a significant upswing in cloud adoption across sectors. At VMware we strive to help our customers manage their cloud infrastructure seamlessly and efficiently for maximum ROI. With CloudHealth, organisations in India can effectively manage multiple cloud environments through a single pane of glass. Our partnership with Netmagic will enable a wide range of Indian customers to benefit from our unified cloud management solutions and help accelerate the Indian cloud adoption narrative further.” David Bate, VP, Cloud, VMware Asia Pacific & Japan, VMware, said, “Enterprises in APJ are embracing a multi-cloud model and are looking for ways to assemble, deploy, shift and manage workloads across their hybrid cloud environment.  The partnership with Netmagic will bring together the capabilities for delivering cloud infrastructure, consumption and resource management to customers in India. We are excited to support their journey and are confident that SimpliInsight Services powered by VMware CloudHealth will utilise our platform to deliver a fully automated cloud management experience.”Reference:  [1] https://datacenternews.us/story/cloud-wins-big-in-q1-2020-as-remote-work-drives-record-demand Menopause to become the next game-changer in global femtech solutions industry by 2025 Comments (0) Add Commentlast_img read more

Zyter launches IoT solution for smart hospitals

first_imgZyter launches IoT solution for smart hospitals WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” A major reason why most app projects fail is due to poor partner selection. As most companies focus only on effective pricing they fail to account for quality, which in turn leads to a lackluster customer experience. So, it is a must to find an experienced mobile app development company like Hakuna Matata Solutions who have more than 14 years of experience in building mobile apps for enterprises Adoption of AI/ML can disrupt healthcare services Share Read Article Related Posts digital healthIoTZyter Smart Hospitals MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Phoenix Business Consulting invests in telehealth platform Healpha By EH News Bureau on January 12, 2021 IoT app development company 5 months Using Bluetooth-connected devices, Zyter Smart Hospitals can monitor medication temperature and alert on any changes, as well as monitor the entire chain of custody of a vaccine from production, to the hospital, to the time it is given to the patientZyter, Inc., a Rockville, Md based digital health and IoT-enablement platform, launched Zyter Smart Hospitals, an end-to-end intelligent solution that connects a hospital’s disparate data systems, departments, people, and the latest Internet of Things (IoT) technology devices on Zyter’s robust digital communication and collaboration platform.According to a company release, the solution is highly secure, HIPAA compliant, and customisable. Zyter Smart Hospitals integrates patient medical device monitoring at the hospital bedside and at home, patient tracking, care team collaborative communication, and medical asset monitoring and tracking through an entire network of connected IoT devices and sensors. Zyter’s comprehensive solution also features a hospital navigation mobile application for patients and visitors, as well as smart, real-time monitoring capabilities for hospital building facilities such as HVAC systems, lighting, security systems, and more.Sanjay Govil, founder and CEO, Zyter believes that with Zyter, the next generation of smart and digitally connected hospitals will gain the competitive advantage of a safer and more personal patient experience, improved operational efficiencies for physicians and staff, and reduced building maintenance costs due to smarter energy management.The key features of Zyter Smart Hospitals include:Hospital Bed Device Monitoring – Improves patient safety and outcomes by collecting and providing nursing staff with real-time physiologic data from all the various medical devices connected to the patient.Mobile Navigation App – A Bluetooth-enabled app on mobile devices guides patients with step-by-step directions to locations within the hospital for a safer, seamless  and more satisfying patient experience.Asset Monitoring – Provides a single interface for improved monitoring, control, and safety of all critical medical assets, including medical equipment, medicines, and vaccines. Using Bluetooth-connected devices, Zyter Smart Hospitals can monitor medication temperature and alert on any changes, as well as monitor the entire chain of custody of a vaccine from production, to the hospital, to the time it is given to the patient.Smart Facilities – Leverages transformative technologies such as 5G, artificial intelligence (AI) and IoT to ensure smart energy management for lighting, power supply, smart meters, HVAC, and wireless power.Patient Tracking – Detects and alerts staff whenever a disoriented dementia patient, or any flight-risk patient, attempts to leave the hospital room or building exits.Patient Monitoring – Enables physicians to monitor the condition of post-surgery patients at home, resulting in better patient outcomes and a reduction of the number of hospital readmissions.  Patients use a pre-programmed 4G-enabled device that automatically tracks and transmits date from their home medical devices to their physician.Ready for 5G connectivity, Zyter Smart Hospitals enables hospitals of all sizes to easily upgrade from legacy hard-wired IT and Wi-Fi systems to a private 5G-enabled IT or cellular network that supports multiple IoT devices.  Zyter partners with Qualcomm and other leading telecom companies to provide hospitals with access to enhanced connectivity services. Zyter solutions are sold globally and the company has a direct sales presence in India as well. Comments (1) Healthcare IT Hospital Infra News Add Comment Menopause to become the next game-changer in global femtech solutions industry by 2025 The missing informal workers in India’s vaccine storylast_img read more

Work on Eastbound Leg of Portmore Highway to be Completed by Aug. 31

first_imgWork on Eastbound Leg of Portmore Highway to be Completed by Aug. 31 TransportAugust 22, 2010 RelatedWork on Eastbound Leg of Portmore Highway to be Completed by Aug. 31 RelatedWork on Eastbound Leg of Portmore Highway to be Completed by Aug. 31 Advertisementscenter_img RelatedWork on Eastbound Leg of Portmore Highway to be Completed by Aug. 31 FacebookTwitterWhatsAppEmail Technical Manager of the National Road Operating and Constructing Company Limited (NROCC), Desmond Martin, says Phase I of corrective works being effected on the eastbound carriageway of the Portmore leg of Highway 2000, in St. Catherine, is on target for completion by August 31.The works, which commenced in May, are being undertaken by Highway 2000 developers, French firm, Bouygues, to correct a depression along the roadway, in the vicinity of the Kingston Port. The NROCC is also involved in the exercise.Speaking at a stakeholders meeting at the Toll Authority office, in Portmore, today (August 21), Mr. Martin advised that work undertaken thus far has “gone very well,” with most of the job already completed. Against this background, he said the developers expect to complete the remaining works “within the target,” by month end. He advised that Phase II of the work is slated to begin on August 27, and end in December.Citing the inconvenience, which motorists have encountered during the first phase, Mr. Martin said this has been reviewed and discussed with the relevant stakeholders, including the Portmore Citizens Advisory Council (PCAC), which was represented at today’s meeting by Chairman, Winston Wright.“We have looked back at what we planned to do, and have come up with some improvements to what we did in the first (phase), to apply these to the second phase, in order to improve the service which the people of Portmore will have on the road,” Mr. Martin assured.last_img read more